TLDR
- Oklo shares climbed 14.8% Monday, extending gains to three consecutive sessions
- U.S. Energy Department’s $2.7 billion uranium funding program sparked rally across nuclear energy stocks
- House subcommittee plans formal review of nuclear industry licensing and deployment policies
- Company has DOE contracts for domestic fuel supply chain development but awaits regulatory approval
- Analysts project revenue could exceed $21 billion by 2038 with price target at $130.10 per share
Oklo shares posted a 14.8% gain on Monday, closing at $89.34 as nuclear energy stocks rallied on fresh government support. The advance marked the third straight trading day of increases for the microreactor developer.
Nuclear sector peers joined the rally. NuScale Power Corp. rose 15% while Nano Nuclear added 12% during the session.
The Energy Department revealed $2.7 billion in uranium-enrichment funding. The program includes high-assay low-enriched uranium production, a critical component for advanced reactor designs.
Fuel availability has constrained Oklo’s development timeline. The company’s Aurora Powerhouse systems require HALEU to operate.
Weekend geopolitical developments in Venezuela added momentum to energy-related equities. The events heightened focus on domestic energy security and supply concerns.
Policy Review and Federal Partnerships
The House Energy subcommittee confirmed plans for hearings on nuclear sector status. Officials will examine current licensing processes and evaluate how existing legislation supports expansion.
The review stems from President Trump’s 2024 executive directive. That order called for accelerated nuclear development to address projected power demands from AI infrastructure and manufacturing growth.
Oklo holds several Department of Energy agreements. The contracts support pilot programs aimed at building domestic reactor fuel production capabilities.
The company specializes in small modular reactor technology for commercial applications. Its first 75-megawatt Aurora Powerhouse unit still requires Nuclear Regulatory Commission approval.
Operations aren’t scheduled to start until the 2027-2028 timeframe. Regulatory clearance remains the primary near-term hurdle.
Wall Street Outlook and Business Model
Analyst Sameer Joshi at H.C. Wainwright maintained his Buy rating last month. His analysis emphasized Oklo’s diversified revenue approach.
The business model encompasses three revenue streams. Power generation from deployed reactors forms the first component.
HALEU fuel manufacturing and sales represent the second pillar. Radioisotope commercialization rounds out the strategy.
Financial forecasts show steep revenue acceleration. Models anticipate annual sales topping $21 billion within 12 years assuming full facility buildout.
Margin profiles look attractive once production reaches scale. The stock has tripled in value over 12 months as investors anticipate nuclear power’s role in data center expansion.
The analyst community rates the stock Moderate Buy overall. Thirteen analysts cover the name, with eight at Buy and five at Hold.
The consensus price objective stands at $130.10. That level implies 45.6% appreciation from the current quote.
Risk factors center on valuation and capital requirements. Building nuclear infrastructure demands substantial upfront investment.
The uranium funding announcement addresses one operational constraint. Government backing could accelerate fuel supply development and production schedules.
Oklo’s year-to-date performance reached 21% following Monday’s advance. The stock has benefited from broader interest in nuclear solutions for baseload power generation.
Get 3 Free Stock Ebooks
Discover top-performing stocks in AI, Crypto, and Technology with expert analysis.
- Top 10 AI Stocks - Leading AI companies
- Top 10 Crypto Stocks - Blockchain leaders
- Top 10 Tech Stocks - Tech giants
